Volume 67, Issue 5, Pages (May 2005)

Slides:



Advertisements
Similar presentations
Volume 64, Issue 6, Pages (December 2003)
Advertisements

Volume 63, Issue 2, Pages (February 2003)
Volume 54, Issue 2, Pages (August 1998)
Volume 64, Issue 4, Pages (October 2003)
Volume 66, Issue 1, Pages (July 2004)
Volume 74, Issue 11, Pages (December 2008)
Inflammatory cytokines in acute renal failure
Volume 77, Issue 9, Pages (May 2010)
Volume 67, Issue 5, Pages (May 2005)
Volume 64, Issue 5, Pages (November 2003)
Simvastatin attenuates cardiac isograft ischemia-reperfusion injury by down-regulating CC chemokine receptor-2 expression  Rong Yin, MD, Jiaquan Zhu,
Volume 78, Issue 3, Pages (August 2010)
Volume 85, Issue 4, Pages (April 2014)
Volume 81, Issue 9, Pages (May 2012)
Volume 71, Issue 6, Pages (March 2007)
Li-Wen Lai, Kim-Chong Yong, Yeong-Hau H. Lien  Kidney International 
Volume 65, Issue 2, Pages (February 2004)
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Volume 67, Issue 2, Pages (February 2005)
Volume 63, Issue 6, Pages (June 2003)
Volume 74, Issue 11, Pages (December 2008)
Volume 82, Issue 3, Pages (August 2012)
Volume 75, Issue 2, Pages (January 2009)
Volume 63, Issue 4, Pages (April 2003)
Volume 70, Issue 2, Pages (July 2006)
Volume 61, Issue 5, Pages (May 2002)
Volume 62, Issue 5, Pages (November 2002)
Oral hydrogen water prevents chronic allograft nephropathy in rats
Volume 60, Issue 2, Pages (August 2001)
Volume 55, Issue 2, Pages (February 1999)
Volume 61, Issue 3, Pages (March 2002)
Volume 61, Issue 5, Pages (May 2002)
Volume 83, Issue 3, Pages (March 2013)
Volume 69, Issue 10, Pages (May 2006)
Volume 73, Issue 12, Pages (June 2008)
COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex  Klaus Höcherl, Christoph Schmidt,
Volume 63, Issue 2, Pages (February 2003)
Volume 64, Issue 3, Pages (September 2003)
Volume 63, Issue 5, Pages (May 2003)
Volume 74, Issue 5, Pages (September 2008)
Volume 85, Issue 4, Pages (April 2014)
Volume 66, Issue 1, Pages (July 2004)
Volume 74, Issue 1, Pages (July 2008)
Volume 74, Issue 11, Pages (December 2008)
Volume 61, Issue 1, Pages (January 2002)
Volume 60, Issue 6, Pages (December 2001)
Volume 69, Issue 10, Pages (May 2006)
Counteracting progression of renal disease: A look into the future
Babu J. Padanilam, Andrew J.P. Lewington, Marc R. Hammerman 
Volume 67, Issue 5, Pages (May 2005)
Volume 63, Issue 1, Pages (January 2003)
MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis  Sang-Kyung Jo, Won Yong Cho, Su Ah Sung, Hyoung.
Florian E. Togel, Christof Westenfelder 
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Ganesan Ramesh, W. Brian Reeves  Kidney International 
Endothelin antagonists in renal disease
Volume 71, Issue 11, Pages (June 2007)
Volume 80, Issue 10, Pages (November 2011)
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes  Guorong Ma, Terri J. Allen, Mark E. Cooper,
Volume 58, Issue 5, Pages (November 2000)
David A. Ferenbach, David C. Kluth, Jeremy Hughes  Kidney International 
Toward a B-cell signature of tolerance?
The more or less ‘pristine’ renal allograft biopsy
Volume 60, Issue 3, Pages (September 2001)
Volume 64, Issue 6, Pages (December 2003)
Volume 65, Issue 3, Pages (March 2004)
Volume 74, Issue 8, Pages (October 2008)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies  Michael Eikmans, Hans J. Baelde, Emile De Heer,
Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis  Nauman Siddiqi, Maureen A. McBride,
Presentation transcript:

Volume 67, Issue 5, Pages 1753-1761 (May 2005) Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion  Daniela Cugini, Nadia Azzollini, Elena Gagliardini, Paola Cassis, Riccardo Bertini, Francesco Colotta, Marina Noris, Giuseppe Remuzzi, Ariela Benigni  Kidney International  Volume 67, Issue 5, Pages 1753-1761 (May 2005) DOI: 10.1111/j.1523-1755.2005.00272.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Experimental design. (A) To assess the kinetics of CINC-1/interleukin-8 (IL-8) expression and intragraft granulocyte infiltration following ischemia/reperfusion (I/R) injury in syngeneic and allogeneic transplantation, rats recipients of syngeneic or allogeneic kidneys underwent a graft biopsy 1 hour after transplantation; theareafter, kidneys were taken at sacrifice 3 or 24 hours after transplantation. (B) Different doses of repertaxin were given to recipents rats to assess the effect of CXCR2 inhibition on granulocyte infiltration and renal function in syngeneic transplantation model. (C) Syngeneic recipent rats were given repertaxin at different pretreatment time before transplantation. (D) repertaxin was given to Brown Norway rats receiving a Lewis allogeneic kidney. Closed arrows are renal tissue taken for analysis; open arrows are measurement of serum creatinine levels. Kidney International 2005 67, 1753-1761DOI: (10.1111/j.1523-1755.2005.00272.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Kinetics of CINC-1/interleukin-8 (IL-8) mRNA expression and granulocyte infiltration after renal ischemia/reperfusion (I/R). Syngeneic and allogeneic renal tissues were analyzed at different time points [1 hour (N = 6); 3 hours (N = 3); and 24 hours (N = 3)] after transplantation. (A) cDNA from kidneys were analyzed by real-time polymerase chain reaction (PCR) to quantify CINC-1/IL-8 mRNA expression. The expression level in the calibrator (control kidney, zero hour) is set to 1 (arbitrary unit). (B) Number of granulocytes counted in intraglomerular (left) and in interstitial (right) areas in at least 10 randomly selected high-power macroscopic fields (HPF). Data are mean ± SE. #P < 0.01 vs. control kidney; *P < 0.05 vs. control kidney; †P < 0.05 vs. 1 hour; and §P < 0.05 vs. 3 hours. Kidney International 2005 67, 1753-1761DOI: (10.1111/j.1523-1755.2005.00272.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Effect of different doses of repertaxin [5 mg/kg(N = 5); 15 mg/kg(N = 6); and 30 mg/kg(N = 3)] or vehicle(N = 8)on intragraft granulocyte infiltration and serum creatinine concentrations in syngeneic transplantation. (A) Number of granulocytes counted in intraglomerular (left) and in interstitial (right) areas 24 hours after reperfusion, in at least 10 randomly selected high power fields (HPF). (B) Dashed line represents normal serum creatinine values. After transplantation the serum creatinine concentrations were evaluated at 16 and 24 hours. Data are mean ± SE. *P < 0.05; °P < 0.001 vs. vehicle. Kidney International 2005 67, 1753-1761DOI: (10.1111/j.1523-1755.2005.00272.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Effect of different administration times of repertaxin 15mg/kg (-2, 0, +2 hours)(N = 8); (-8, 0, +2 hours)(N = 4); or vehicle(N = 13)on intragraft granulocyte infiltration and serum creatinine concentrations in syngeneic transplantation. (A) Number of granulocytes counted in intraglomerular (left) and in interstitial (right) areas 24 hours after reperfusion, in at least 10 randomly selected high power fields (HPF). (B) Dashed line represents normal serum creatinine values. After transplantation the serum creatinine concentrations were evaluated at 16 and 24 hours. Data are mean ± SE. †P < 0.001; *P < 0.01; #P < 0.05; §P < 0.005 vs. vehicle; °P < 0.05 vs. repertaxin at -2, 0, +2 hours. Kidney International 2005 67, 1753-1761DOI: (10.1111/j.1523-1755.2005.00272.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Effect of repertaxin (15mg/kg) (-8, 0, +2 hours(N = 10)or vehicle(N = 13)on intragraft granulocyte infiltration and serum creatinine concentrations in allogeneic transplantation. (A) Number of granulocytes counted in intraglomerular (left) and in interstitial (right) areas 24 hours after reperfusion, in at least 10 randomly selected high power fields (HPF). (B) Dashed line represents normal serum creatinine values. After transplantation the serum creatinine concentrations were evaluated at 16 and 24 hours. Data are mean ± SE. °P < 0.05 vs. vehicle. Kidney International 2005 67, 1753-1761DOI: (10.1111/j.1523-1755.2005.00272.x) Copyright © 2005 International Society of Nephrology Terms and Conditions